| [1] |
Williams RL, Urbé S. The emerging shape of the ESCRT machinery [J]. Nat Rev Mol Cell Biol, 2007, 8(5): 355-368.
|
| [2] |
Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles [J]. Annu Rev Cell Dev Biol, 2014, 30(8): 255-289.
|
| [3] |
Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication [J]. Journal of proteomics, 2010, 73(10): 1907-1920.
|
| [4] |
Xin H, Li Y, Buller B, et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth [J]. Stem cells (Dayton, Ohio), 2012, 30(7): 1556-1564.
|
| [5] |
Wang S, Cesca F, Loers G, et al. Synapsin I is an oligomannosecarrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes [J]. The Journal of neuroscience: the officialjournal of the Society for Neuroscience, 2011, 31(20): 7275-7290.
|
| [6] |
Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles [J]. The Journal of experimental medicine, 1996, 183(3): 1161-1172.
|
| [7] |
Au Yeung CL, Co NN, Tsuruga T, et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1 [J]. Nat Commun, 2016, 29(7): 11150.
|
| [8] |
Kogure T, Lin WL, Yan IK, et al. Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth [J]. Hepatology, 2011, 54(4): 1237-1248.
|
| [9] |
Roccaro AM, Sacco A, Maiso P, et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression [J]. Clin Invest, 2013, 123(4): 1542-1555.
|
| [10] |
Kosaka N, Iguchi H, Hagiwara K, et al. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis[J], Biol Chem, 2013, 288(15): 10849-10859.
|
| [11] |
Mincheva-Nilsson L, Baranov V. Cancer exosomes and NKG2D receptor-ligand interations: Impairing NKG2D mediated cytotoxicity and anti-tumor immune surveillance [J]. Semin Cancer Biol, 2014, 28: 24-30.
|
| [12] |
Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer [J]. Gynecol Oncol, 2008, 110(1): 13-21.
|
| [13] |
Zhu M, Huang Z, Zhu D, et al. A panel of microRNA signature in serum for colorectal cancer diagnosis [J]. Oncotarget, 2017, 8(10): 17081-17091.
|
| [14] |
Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer [J]. Nature, 2015, 523(7559): 177-182.
|
| [15] |
Manier S, Liu CJ, Avet-Loiseau H, et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma [J]. Blood, 2017, 129(17): 2429-2436.
|
| [16] |
Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma [J]. N Engl J Med, 2005, 352(10): 997-1003.
|
| [17] |
Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J]. Nat Biotechnol, 2011, 29(4): 341-345.
|
| [18] |
Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy [J]. Biomaterials, 2014, 35(7): 2383-2390.
|
| [19] |
Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells [J]. Nanomedicine, 2016, 12(3): 655-664.
|
| [20] |
Katakowski M, Buller B, Zheng X, et al. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth [J]. Cancer Lett, 2013, 335(1): 201-204.
|
| [21] |
Ono M, Kosaka N, Tominaga N, et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells [J]. Sci Signal, 2014, 7(332): ra63.
|